Paul W. Hoelscher
2014
In 2014, Paul W. Hoelscher earned a total compensation of $3.4M as Executive Vice President, Chief Financial Officer at Horizon Pharma.
Compensation breakdown
| Non-Equity Incentive Plan | $400,000 |
|---|---|
| Option Awards | $1,024,291 |
| Salary | $210,920 |
| Stock Awards | $1,276,800 |
| Other | $531,445 |
| Total | $3,443,456 |
Hoelscher received $1.3M in stock awards, accounting for 37% of the total pay in 2014.
Hoelscher also received $400K in non-equity incentive plan, $1M in option awards, $210.9K in salary and $531.4K in other compensation.
Rankings
In 2014, Paul W. Hoelscher's compensation ranked 2,547th out of 13,032 executives tracked by ExecPay. In other words, Hoelscher earned more than 80.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,547 out of 13,032 | 81st |
Division Manufacturing | 905 out of 4,966 | 82nd |
Major group Chemicals And Allied Products | 279 out of 1,686 | 84th |
Industry group Drugs | 216 out of 1,365 | 84th |
Industry Pharmaceutical Preparations | 178 out of 1,043 | 83rd |
Source: SEC filing on April 3, 2017.
Hoelscher's colleagues
We found three more compensation records of executives who worked with Paul W. Hoelscher at Horizon Pharma in 2014.
News
Horizon Pharma CEO Timothy Walbert's 2021 pay slips 1% to $21M
March 17, 2022
Horizon Pharma CEO Timothy Walbert's 2020 pay jumps 56% to $22M
March 17, 2021
Horizon Pharma CEO Timothy Walbert's 2019 pay slips 17% to $14M
March 18, 2020
Horizon Pharma CEO Timothy Walbert's 2018 pay jumps 617% to $17M
April 8, 2019